What this biotech's volatile stock price tells you about the weight loss market right now
AI disclosure
Summary
While the market's enthusiasm for one of Zealand's experimental drugs has cooled, investors are shifting focus to amylin-based medicines as a growth driver
Discussion on
Trending posts from X.
The market is afraid AI agents will disrupt SaaS.
— The Assembly (@InTheAssembly) June 18, 2026
Jensen is proving the opposite. ServiceNow is the platform the agentic AI revolution will run on.
The stock has not taken off yet. That is exactly what makes it interesting to me right now.
Not financial advice.